Analysis of peginterferon β-1a exposure and Gd-enhanced lesion or T2 lesion response in relapsing-remitting multiple sclerosis patients.

Hang Y, Hu X, Zhang J, Liu S, Deykin A, Nestorov I

J Pharmacokinet Pharmacodyn. 2016 Aug; 43(4):371-83. Epub 2016 Jun 14. PMID: 27299457. Abstract